Cargando…
Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
Berberine (BBR) has been confirmed to have multiple bioactivities in clinic, such as cholesterol-lowering, anti-diabetes, cardiovascular protection and anti- inflammation. However, BBR’s plasma level is very low; it cannot explain its pharmacological effects in patients. We consider that the in vivo...
Autores principales: | Tan, Xiang-Shan, Ma, Jing-Yi, Feng, Ru, Ma, Chao, Chen, Wen-Jing, Sun, Yu-Peng, Fu, Jie, Huang, Min, He, Chi-Yu, Shou, Jia-Wen, He, Wen-Yi, Wang, Yan, Jiang, Jian-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815028/ https://www.ncbi.nlm.nih.gov/pubmed/24205048 http://dx.doi.org/10.1371/journal.pone.0077969 |
Ejemplares similares
-
Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018) -
Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015) -
Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
por: Li, Xiao-Yang, et al.
Publicado: (2015) -
In Vivo Metabolite Profiling of a Purified Ellagitannin Isolated from Polygonum capitatum in Rats
por: Ma, Jing-Yi, et al.
Publicado: (2016) -
Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017)